Semler Scientific Inc SEC Filings

Strive, Inc. reposted a communication on X from board member Pierre Rochard regarding its proposed business combination with Semler Scientific (SMLR). The notice reiterates forward‑looking statement cautions and points investors to SEC filings for details.

Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication also outlines where to access the S-4, related amendments, and future materials, and clarifies that this is not an offer to sell or solicit securities.

Strive, Inc. released a communication under Rule 425 about its proposed business combination with Semler Scientific, Inc. (SMLR). The message includes a broad forward‑looking statements disclaimer highlighting uncertainties around timing, integration and expected strategic and financial benefits.

Strive has filed a Registration Statement on Form S‑4 that will include an information statement of Strive, a proxy statement of Semler Scientific and a prospectus of Strive. Semler Scientific stockholders will receive a definitive document to vote on the transaction, and investors are urged to read the Registration Statement and related materials when available on the SEC’s website. The communication also states it is not an offer or solicitation to sell securities.

Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.

A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The companies emphasize forward-looking statement cautions, outline where investors can access SEC filings, note that directors and officers may be participants in the proxy solicitation, and clarify that this communication is not an offer or solicitation.

Strive, Inc. reposted on X a communication about its proposed business combination with Semler Scientific (SMLR). The message includes a forward‑looking statements caution and notes that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction.

A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval, and investors are urged to read these materials when available. Documents will be accessible free of charge on the SEC’s website and via company investor relations pages. The communication also states it is not an offer or solicitation to buy or sell securities.

Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific (SMLR), noting that CEO Matthew Cole reposted the communication on X.com on November 12, 2025.

Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in connection with the transaction. The S-4 will include an information statement/proxy statement/prospectus, and a definitive version will be sent to Semler stockholders to seek approval of the proposed transaction.

The notice includes extensive forward‑looking statement disclaimers and directs investors to read the S-4 and related materials when available, which will be accessible free of charge on the SEC’s website and the companies’ investor sites.

Semler Scientific (SMLR) announced a Bitcoin information dashboard on its website as a Regulation FD disclosure channel, providing broad, non‑exclusionary updates on its Bitcoin holdings, market data, and KPIs such as BTC Yield, BTC Gain, and BTC $ Gain. The company states that some information posted there may be material.

Semler reported BTC Yield of 0.9% for the third quarter of 2025 and 30.6% year‑to‑date through November 10, 2025, a KPI used to assess its strategy of acquiring Bitcoin, including when funded by issuing common stock or convertible instruments. The information in Item 7.01 is furnished, not filed.

Semler Scientific reported Q3 2025 results. Revenue was $7,491, down from $13,512 a year ago, as most sales came from equipment leases and lower variable-fee licenses. Despite the revenue decline, net income rose to $16,902, helped by a $28,490 change in fair value of intangible digital assets and a $1,471 gain on Bitcoin collateral revaluation. Diluted EPS was $1.07.

Intangible digital assets were carried at $539,844 at quarter end; the company held approximately 4,733 Bitcoins, excluding 315 pledged as collateral. A $20,000 short‑term Coinbase loan is secured by those 315 Bitcoins, and the related receivable for Bitcoin collateral was $35,928. In January, the company issued $100,000 of 4.25% convertible senior notes due 2030 (carrying value $96,418). Cash from financing was $320,458, including $214,964 from ATM equity sales, while investing used $284,757 largely for Bitcoin purchases.

The company paid a $29,750 DOJ settlement plus accrued interest in September and entered into a five‑year corporate integrity agreement with HHS OIG.

Strive, Inc. announced a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive definitive materials to vote on the proposed transaction.

The notice includes a forward-looking statements caution, identifies potential proxy solicitation participants, and clarifies this is not an offer or solicitation. Related documents will be available free of charge at SEC.gov and the companies’ investor relations websites.

Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The notice reiterates standard forward‑looking statement cautions and directs investors to SEC filings for details.

Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, with related Information Statement/Proxy Statement/Prospectus materials, including versions filed on August 6, 2025 and October 10, 2025. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.

The communication emphasizes that it is not an offer to sell or solicit an offer to buy securities. Investors are urged to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and company investor sites.